ITTO20040124A1 - Nuovi impieghi in terapia di derivati di n-piperidina particolarmente per il trattamento di patologie neurodegenerative - Google Patents
Nuovi impieghi in terapia di derivati di n-piperidina particolarmente per il trattamento di patologie neurodegenerativeInfo
- Publication number
- ITTO20040124A1 ITTO20040124A1 IT000124A ITTO20040124A ITTO20040124A1 IT TO20040124 A1 ITTO20040124 A1 IT TO20040124A1 IT 000124 A IT000124 A IT 000124A IT TO20040124 A ITTO20040124 A IT TO20040124A IT TO20040124 A1 ITTO20040124 A1 IT TO20040124A1
- Authority
- IT
- Italy
- Prior art keywords
- therapy
- treatment
- piperidine derivatives
- new uses
- neurodegenerative pathologies
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000124A ITTO20040124A1 (it) | 2004-03-01 | 2004-03-01 | Nuovi impieghi in terapia di derivati di n-piperidina particolarmente per il trattamento di patologie neurodegenerative |
KR1020067020673A KR101244799B1 (ko) | 2004-03-01 | 2005-02-22 | 신경퇴행성 병을 치료하기 위한 n-피페리딘 유도체의 용도 |
CA2556383A CA2556383C (en) | 2004-03-01 | 2005-02-22 | Use of n-piperidine derivatives for the treatment of neurodegenerative pathologies |
PCT/EP2005/001818 WO2005084677A1 (en) | 2004-03-01 | 2005-02-22 | Use of n-piperidine derivatives for the treatment of neurodegenerative pathologies |
EP05715443A EP1727545B1 (en) | 2004-03-01 | 2005-02-22 | Use of n-piperidine derivatives for the treatment of neurodegenerative pathologies |
US10/589,469 US8461186B2 (en) | 2004-03-01 | 2005-02-22 | Use of N-piperidine derivatives for the treatment of neurodegenerative pathologies |
AU2005218739A AU2005218739A1 (en) | 2004-03-01 | 2005-02-22 | Use of N-piperidine derivatives for the treatment of neurodegenerative pathologies |
PL05715443T PL1727545T3 (pl) | 2004-03-01 | 2005-02-22 | Zastosowanie pochodnych N-piperydyny do leczenia patologii neurodegeneracyjnych |
ES05715443T ES2392846T3 (es) | 2004-03-01 | 2005-02-22 | Uso de derivados de N-piperidina para el tratamiento de patologías neurodegenerativas |
RU2006134643/15A RU2377986C2 (ru) | 2004-03-01 | 2005-02-22 | Применение производных n-пиперидина для лечения нейродегенеративных патологий |
CN2005800066332A CN1946400B (zh) | 2004-03-01 | 2005-02-22 | N-哌啶衍生物用于治疗神经变性疾病的应用 |
BRPI0507817-2A BRPI0507817A (pt) | 2004-03-01 | 2005-02-22 | uso de derivados n-piperidina para o tratamento de patologias neurodegenerativas |
JP2007501168A JP2007525530A (ja) | 2004-03-01 | 2005-02-22 | 神経変性病変の治療におけるn−ピペリジン誘導体の使用 |
NO20064426A NO20064426L (no) | 2004-03-01 | 2006-09-29 | Anvendelse av N-piperidinderivater til behandling av neurodegenerative patologier |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000124A ITTO20040124A1 (it) | 2004-03-01 | 2004-03-01 | Nuovi impieghi in terapia di derivati di n-piperidina particolarmente per il trattamento di patologie neurodegenerative |
Publications (1)
Publication Number | Publication Date |
---|---|
ITTO20040124A1 true ITTO20040124A1 (it) | 2004-06-01 |
Family
ID=34917559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT000124A ITTO20040124A1 (it) | 2004-03-01 | 2004-03-01 | Nuovi impieghi in terapia di derivati di n-piperidina particolarmente per il trattamento di patologie neurodegenerative |
Country Status (14)
Country | Link |
---|---|
US (1) | US8461186B2 (it) |
EP (1) | EP1727545B1 (it) |
JP (1) | JP2007525530A (it) |
KR (1) | KR101244799B1 (it) |
CN (1) | CN1946400B (it) |
AU (1) | AU2005218739A1 (it) |
BR (1) | BRPI0507817A (it) |
CA (1) | CA2556383C (it) |
ES (1) | ES2392846T3 (it) |
IT (1) | ITTO20040124A1 (it) |
NO (1) | NO20064426L (it) |
PL (1) | PL1727545T3 (it) |
RU (1) | RU2377986C2 (it) |
WO (1) | WO2005084677A1 (it) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1815741B1 (en) * | 2006-01-19 | 2011-07-06 | Medestea Research & Production S.p.A. | Use of n-piperidine derivative compositions for protecting biological systems |
US20090234150A1 (en) * | 2006-07-14 | 2009-09-17 | Peter Carmeliet | Use of ppar-alpha agonists to treat skeletal muscle wasting disorders |
CA2696310A1 (en) * | 2007-08-14 | 2009-02-19 | Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services, The | Method of treating disease involving myelin and/or axonal loss |
KR101491763B1 (ko) * | 2013-12-19 | 2015-02-16 | 대한민국 | 1-(2-((4-클로로-2-메톡시-5-메칠페닐)아미노)-2-옥소에틸)-n-(2-하이드록시페닐)-피페리딘-4-카복사마이드 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 프리온 질환 예방 및 치료용 약학적 조성물 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4590231A (en) * | 1983-10-11 | 1986-05-20 | Ciba-Geigy Corporation | Polyolefin compositions stabilized against degradation using hydroxylamine derivatives |
US4691015A (en) | 1984-07-23 | 1987-09-01 | Ciba-Geigy Corporation | Hydroxylamines derived from hindered amines |
US4883666A (en) | 1987-04-29 | 1989-11-28 | Massachusetts Institute Of Technology | Controlled drug delivery system for treatment of neural disorders |
US5036097A (en) * | 1989-10-17 | 1991-07-30 | Oklahoma Medical Research Foundation | Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration |
CA2072934C (en) | 1991-07-19 | 2007-08-28 | Karl William Aston | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
US5696109A (en) | 1992-12-07 | 1997-12-09 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
AU1947395A (en) | 1994-02-28 | 1995-09-11 | Medinova Medical Consulting Gmbh | Drug targeting system, method for preparing same and its use |
WO1996015110A1 (en) | 1994-11-15 | 1996-05-23 | Moreno Paolini | N-hydroxypiperidines as superoxide radicals scavengers |
US6420429B1 (en) * | 1997-12-23 | 2002-07-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Brain targeted low molecular weight hydrophobic antioxidant compounds |
AU1186300A (en) * | 1998-11-25 | 2000-06-13 | Daiichi Radioisotope Laboratories, Ltd. | Drugs and reagents containing n-acyloxylated cycloalkyl compounds as the active ingredient |
JP2004510735A (ja) | 2000-10-05 | 2004-04-08 | ファルマシア・コーポレイション | スーパーオキシドの不均化用触媒を含む組成物ならびに低血圧症を予防および治療するための当該組成物の使用 |
AU2002236861A1 (en) | 2001-01-26 | 2002-08-06 | Metaphore Pharmaceuticals, Inc. | Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes |
US20050065182A1 (en) * | 2003-09-23 | 2005-03-24 | Papazoglou Elisabeth S. | Method and compositions for chronic wound care |
US7531555B2 (en) * | 2003-10-01 | 2009-05-12 | University Of Florida Research Foundation, Inc. | Compositions and methods for selective inhibition of nicotine acetylcholine receptors |
-
2004
- 2004-03-01 IT IT000124A patent/ITTO20040124A1/it unknown
-
2005
- 2005-02-22 CA CA2556383A patent/CA2556383C/en not_active Expired - Fee Related
- 2005-02-22 WO PCT/EP2005/001818 patent/WO2005084677A1/en active Application Filing
- 2005-02-22 BR BRPI0507817-2A patent/BRPI0507817A/pt not_active IP Right Cessation
- 2005-02-22 US US10/589,469 patent/US8461186B2/en not_active Expired - Fee Related
- 2005-02-22 KR KR1020067020673A patent/KR101244799B1/ko not_active IP Right Cessation
- 2005-02-22 CN CN2005800066332A patent/CN1946400B/zh not_active Expired - Fee Related
- 2005-02-22 PL PL05715443T patent/PL1727545T3/pl unknown
- 2005-02-22 ES ES05715443T patent/ES2392846T3/es active Active
- 2005-02-22 JP JP2007501168A patent/JP2007525530A/ja active Pending
- 2005-02-22 EP EP05715443A patent/EP1727545B1/en not_active Not-in-force
- 2005-02-22 AU AU2005218739A patent/AU2005218739A1/en not_active Abandoned
- 2005-02-22 RU RU2006134643/15A patent/RU2377986C2/ru not_active IP Right Cessation
-
2006
- 2006-09-29 NO NO20064426A patent/NO20064426L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2006134643A (ru) | 2008-04-10 |
US8461186B2 (en) | 2013-06-11 |
KR20060132746A (ko) | 2006-12-21 |
EP1727545A1 (en) | 2006-12-06 |
PL1727545T3 (pl) | 2013-01-31 |
CN1946400B (zh) | 2012-05-09 |
EP1727545B1 (en) | 2012-08-08 |
JP2007525530A (ja) | 2007-09-06 |
KR101244799B1 (ko) | 2013-03-18 |
CA2556383C (en) | 2013-05-14 |
WO2005084677A1 (en) | 2005-09-15 |
RU2377986C2 (ru) | 2010-01-10 |
ES2392846T3 (es) | 2012-12-14 |
BRPI0507817A (pt) | 2007-07-10 |
AU2005218739A1 (en) | 2005-09-15 |
NO20064426L (no) | 2006-11-29 |
CA2556383A1 (en) | 2005-09-15 |
CN1946400A (zh) | 2007-04-11 |
US20070191427A1 (en) | 2007-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120741T1 (el) | Θεραπεια οζωδους σκληρυνσης | |
CR8642A (es) | Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos | |
EP1905456A4 (en) | PHARMACEUTICAL LIGHT-NETWORKED HYALURONIC DERIVATIVE GEL | |
DK1690550T3 (da) | Terapeutisk middel til mesothelioma | |
IL180078A (en) | Derivatives of 9-cis retinal for use in treating deficiency of 11-cis retinal | |
DK3424932T3 (da) | Bronophthalider til terapeutisk anvendelse | |
SMAP200900085A (it) | 3-imidazolil-indoli per il trattamento di malattieproliferative | |
DK1885380T3 (da) | Natriummetaarsenit til anvendelse til behandling af metastatiske neoplastiske sygdomme | |
IS8550A (is) | Imídasól efnasambönd til meðhöndlunar á taugahrörnunarsjúkdómum | |
DK2426106T3 (da) | Piperidin- og piperazinderivat til behandling af tumorer | |
NO20070251A (no) | Brønnbehandling | |
IS8246A (is) | Meðferð á taugahrörnunarástandi | |
NO20070297A (no) | Brønnbehandling | |
IL184934A0 (en) | 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases | |
DK3072507T3 (da) | Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi | |
DE602006013636D1 (de) | Dosiszähler | |
CY2018006I2 (el) | Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας | |
ITRM20050179A1 (it) | Composizione impiegabile per il trattamento delle patologie paradontali. | |
IL177455A0 (en) | Pyrazoline derivatives useful for the treatment of cancer | |
IS7444A (is) | Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum | |
IL188390A0 (en) | Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders | |
BRPI0821026A2 (pt) | Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos | |
PL1727545T3 (pl) | Zastosowanie pochodnych N-piperydyny do leczenia patologii neurodegeneracyjnych | |
TWI350753B (en) | 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain | |
TWI340643B (en) | 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders |